Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Indice SBF 120 | PX4 | May 31, 2024 | 6 067.93 | +0.21 |
Ipsen SA | IPN | May 31, 2024 | 120.60 | +1.01 |
Kering SA | KER | May 31, 2024 | 317.20 | -1.06 |
Klepierre | LI | May 31, 2024 | 26.60 | +2.39 |
La Francaise Des Jeux S.A. | FDJ | May 31, 2024 | 32.96 | -1.14 |
Legrand SA | LR | May 31, 2024 | 99.10 | -2.65 |
LOreal | OR | May 31, 2024 | 452.10 | +1.66 |
Michelin | ML | May 31, 2024 | 37.15 | +0.08 |
Next 150 Index | N150 | May 31, 2024 | 3 513.04 | +0.25 |
Orange. | ORA | May 31, 2024 | 10.73 | +0.70 |
Pernod Ricard SA | RI | May 31, 2024 | 136.95 | -0.04 |
Publicis Groupe SA | PUB | May 31, 2024 | 102.80 | -0.53 |
Remy Cointreau SA | RCO | May 31, 2024 | 85.50 | +0.35 |
Renault SA | RNO | May 31, 2024 | 53.58 | -0.74 |
Rexel | RXL | May 31, 2024 | 27.81 | -1.31 |
Rubis | RUI | May 31, 2024 | 32.70 | +0.99 |
Safran SA | SAF | May 31, 2024 | 214.10 | +0.14 |
Sanofi | SAN | May 31, 2024 | 89.76 | +1.34 |
Sartorius Stedim Biotech, Aubagne Ordinary Shares | DIM | May 31, 2024 | 182.65 | -0.27 |
Schneider Electric SE | SU | May 31, 2024 | 227.45 | -0.52 |
SCOR SE | SCR | May 31, 2024 | 26.48 | +1.85 |
Societe Generale SA | GLE | May 31, 2024 | 27.39 | +0.05 |
Sodexo | SW | May 31, 2024 | 85.70 | +0.29 |
SOLVAY | SOLB | May 31, 2024 | 33.63 | -1.98 |
STMicroelectronics NV | STMPA | May 31, 2024 | 37.85 | +0.19 |
Teleperformance | TEP | May 31, 2024 | 104.40 | +1.56 |
Thales | HO | May 31, 2024 | 166.65 | +1.43 |
Ubisoft Entertainment SA | UBI | May 31, 2024 | 22.42 | +1.26 |
Unibail-Rodamco-Westfield Stapled (2 Ordinary Shares) | URW | May 31, 2024 | 80.66 | +1.13 |
Valeo SA | FR | May 31, 2024 | 11.29 | -0.27 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.